Skip to main contentAccess keys help

[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Tuesday, 22 March, 2005, 07:47 GMT
Jim's Alzheimer's drug plea
actor Jim Broadbent
Jim told us no acting was required for his role in Iris
Living with Alzheimer's disease can be devastating, for patients and their relatives.

There is no cure for this progressive form of dementia.

But, until recently, there was hope that a series of drugs could reduce some of the symptoms - improving sufferers' memories and making daily living tasks easier.

So, it came as a bolt from the blue for many carers when the National Institute for Clinical Excellence recommended withdrawing NHS approval for them

According to NICE, the four drugs - Aricept, Exelon, Reminyl and Ebixa - are not cost-effective.

The drugs cost around �2.50 per patient per day.

  • This morning, Breakfast talked to the actor Jim Broadbent, who campaigns on behalf of Alzheimer's sufferers.

    Jim co-starred in the film Iris, which charted the decline of the novelist Irish Murdoch, who suffered from Alzheimer's disease.

    His own mother also suffered from Alzheimer's.

    He's hoping that NICE can be persuaded to alter its recommendation.

    Today is the last day of NICE's public consultations.

    A final decision on the drugs won't be taken until the end of July - and NICE has already promised that patients who are already taking the drugs won't have their prescriptions withdrawn.



  • BBC NEWS: VIDEO AND AUDIO
    Jim Broadbent on BBC Breakfast
    The Oscar-winning actor told us about his campaign for Alzheimer's sufferers



    SEE ALSO:


    RELATED BBC LINKS:

    RELATED INTERNET LINKS:
    The BBC is not responsible for the content of external internet sites

    PRODUCTS AND SERVICES

    News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East | South Asia
    UK | Business | Entertainment | Science/Nature | Technology | Health
    Have Your Say | In Pictures | Week at a Glance | Country Profiles | In Depth | Programmes
    AmericasAfricaEuropeMiddle EastSouth AsiaAsia Pacific